The Patent Finder

Celltrend GmbH

Also on record
Records under this name other than the patents Celltrend GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 4 of 4 · Back to Celltrend GmbH

PatentTitleStatus Expires Confidence
US 10,802,020Diagnosis of Chronic Fatigue Diseases Using Detection Antibodies Directed Against a β-ADRENERGIC Receptor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,110,374Method for predicting the risk of transplant rejection and immunological testkit
Term ended
Term ended May 24, 2024 · From the USPTO record
Term endedTerm ended May 24, 2024From the USPTO record
US 8,846,324In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
Lapsed on the fee record
Ended Sep 30, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 30, 2022From the USPTO record
US 8,999,338Method for diagnosis for multiple sclerosis involving anti1-receptor antibody
Lapsed on the fee record
Ended Apr 7, 2019 · From the USPTO record
Lapsed on the fee recordEnded Apr 7, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited